Post-Transplant Cyclophosphamide Cardiac Toxicity: RN–APP Collaborative Assessment and Decision-Making
Clinical Journal of Oncology Nursing · 01.06.2026
DOI: 10.1188/26.cjon.187-191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of Oncology Nursing, online erschienen am 02.06.2026. Verfasst von Tia T Wheatley. Beteiligte Einrichtung: Tia T. Wheatley. Hauptthemen laut MEDLINE: Cyclophosphamide, Immunosuppressive Agents, Graft vs Host Disease, Cardiotoxicity. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Post-transplant cyclophosphamide (PTCy) is a widely used therapy for reducing the risk of graft-versus-host disease in patients undergoing allogeneic stem cell transplantation. PTCy has been associated with early cardiac comp.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tia T. Wheatley.
Zitieren
APA
Wheatley, T. T. (2026). Post-Transplant Cyclophosphamide Cardiac Toxicity: RN–APP Collaborative Assessment and Decision-Making. Clinical Journal of Oncology Nursing. https://doi.org/10.1188/26.cjon.187-191
Vancouver
Wheatley TT. Post-Transplant Cyclophosphamide Cardiac Toxicity: RN–APP Collaborative Assessment and Decision-Making. Clinical Journal of Oncology Nursing. 2026. doi:10.1188/26.cjon.187-191
BibTeX
@article{Wheatley2026,
author = {Wheatley, Tia T},
title = {Post-Transplant Cyclophosphamide Cardiac Toxicity: RN–APP Collaborative Assessment and Decision-Making},
journal = {Clinical Journal of Oncology Nursing},
year = {2026},
doi = {10.1188/26.cjon.187-191}
}
EUVIMED